MIDERIZONE

Medicinal product

(Invented) name

MIDERIZONE

Active substance (s)

Tolperizonas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M03BX04, Tolperisone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-12-22

Date of renewal

Documents

3101_MIDERIZONE 150mg_pl_deng_tab_PL_2025-12-22.docx

3101_MIDERIZONE 150mg_pl_deng_tab_PZ_2025-12-22.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Tolperizonas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119549	105655	1105655	lizdinė plokštelė	N30		Receptinis	LT/L/25/3101/001	Netiekiama	-	-	No	-	-	Download
119550	105656	1105656	lizdinė plokštelė	N60		Receptinis	LT/L/25/3101/002	Netiekiama	-	-	No	-	-
119551	105657	1105657	lizdinė kortelė	N90		Receptinis	LT/L/25/3101/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-12-22	Registruotas